Literature DB >> 10069993

A3 adenosine receptors regulate Cl- channels of nonpigmented ciliary epithelial cells.

C H Mitchell1, K Peterson-Yantorno, D A Carré, A M McGlinn, M Coca-Prados, R A Stone, M M Civan.   

Abstract

Adenosine stimulates Cl- channels of the nonpigmented (NPE) cells of the ciliary epithelium. We sought to identify the specific adenosine receptors mediating this action. Cl- channel activity in immortalized human (HCE) NPE cells was determined by monitoring cell volume in isotonic suspensions with the cationic ionophore gramicidin present. The A3-selective agonist N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide (IB-MECA) triggered shrinkage (apparent Kd = 55 +/- 10 nM). A3-selective antagonists blocked IB-MECA-triggered shrinkage, and A3-antagonists (MRS-1097, MRS-1191, and MRS-1523) also abolished shrinkage produced by 10 microM adenosine when all four known receptor subtypes are occupied. The A1-selective agonist N6-cyclopentyladenosine exerted a small effect at 100 nM but not at higher or lower concentrations. The A2A agonist CGS-21680 triggered shrinkage only at high concentration (3 microM), an effect blocked by MRS-1191. IB-MECA increased intracellular Ca2+ in HCE cells and also stimulated short-circuit current across rabbit ciliary epithelium. A3 message was detected in both HCE cells and rabbit ciliary processes using RT-PCR. We conclude that human HCE cells and rabbit ciliary processes possess A3 receptors and that adenosine can activate Cl- channels in NPE cells by stimulating these A3 receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069993     DOI: 10.1152/ajpcell.1999.276.3.C659

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

1.  A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse.

Authors:  M Y Avila; R A Stone; M M Civan
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  Pathways for ATP release by bovine ciliary epithelial cells, the initial step in purinergic regulation of aqueous humor inflow.

Authors:  Ang Li; Chi Ting Leung; Kim Peterson-Yantorno; Claire H Mitchell; Mortimer M Civan
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-06       Impact factor: 4.249

Review 3.  Purinergic regulation of epithelial transport.

Authors:  R Elaine Bucheimer; Joel Linden
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

4.  Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport.

Authors:  J C Fleischhauer; C H Mitchell; W D Stamer; M O Karl; K Peterson-Yantorno; M M Civan
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

Review 5.  Basis of chloride transport in ciliary epithelium.

Authors:  C W Do; M M Civan
Journal:  J Membr Biol       Date:  2004-07-01       Impact factor: 1.843

Review 6.  Mechanisms of ATP release, the enabling step in purinergic dynamics.

Authors:  Ang Li; Juni Banerjee; Chi Ting Leung; Kim Peterson-Yantorno; W Daniel Stamer; Mortimer M Civan
Journal:  Cell Physiol Biochem       Date:  2011-12-16

Review 7.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

8.  Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.

Authors:  Zhao Wang; Chi Wai Do; Marcel Y Avila; Kim Peterson-Yantorno; Richard A Stone; Zhan-Guo Gao; Bhalchandra Joshi; Pedro Besada; Lak Shin Jeong; Kenneth A Jacobson; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2009-10-28       Impact factor: 3.467

Review 9.  Exciting directions in glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman
Journal:  Can J Ophthalmol       Date:  2014-12       Impact factor: 1.882

Review 10.  Purinergic signaling during inflammation.

Authors:  Holger K Eltzschig; Michail V Sitkovsky; Simon C Robson
Journal:  N Engl J Med       Date:  2012-12-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.